NY Times online columnist David Bornstein examines how the Cure Alzheimer’s Fund and other organizations have taken a unique approach to research that is intensely goal-directed and collaborative, focusing on the creation of new cures and potential treatment as a process that needs to be managed. Bornstein notes the Fund has worked to bring a sense of urgency to their research that is resulted oriented.

Read more

Share: